Anti-Halobacterium GvpA scFv 2B10-1-pcDNA 3.4 TOPO
(Plasmid
#174688)
-
PurposePlasmid for recombinant expression in mammalian cells of an anti-Halobacterium salinarum GvpA single chain variable fragment derived from monoclonal antibody 2B10-1
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 174688 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $94 | |
Backbone
-
Vector backbonepcDNA 3.4 TOPO
-
Backbone manufacturerSigma Aldrich
- Backbone size w/o insert (bp) 6011
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsThe depositing lab uses Expi293F human cells for expression.
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameAnti- Halobacterium salinarum GvpA single chain variable fragment 2B10-1
-
Alt nameanti-GvpA scfv
-
SpeciesH. sapiens (human)
-
Insert Size (bp)798
-
MutationNone
- Promoter CMV promoter
-
Tag
/ Fusion Protein
- hemagglutinin (HA) tag, hexahistidine (HIS) tag (C terminal on backbone)
Cloning Information
- Cloning method TOPO Cloning
- 5′ sequencing primer NA
- (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Anti-Halobacterium GvpA scFv 2B10-1-pcDNA 3.4 TOPO was a gift from Jean Gariepy (Addgene plasmid # 174688 ; http://n2t.net/addgene:174688 ; RRID:Addgene_174688) -
For your References section:
Broadly Applicable Bispecific Linker Approach to Noncovalently Target Therapeutic Nanoparticles to Tumor Cells Expressing Carcinoembryonic Antigen. Fernando A, Sparkes A, Matus EI, Patel A, Foster FS, Goertz D, Lee P, Gariepy J. ACS Pharmacol Transl Sci. 2024 Jun 3;7(6):1864-1873. doi: 10.1021/acsptsci.4c00140. eCollection 2024 Jun 14. 10.1021/acsptsci.4c00140 PubMed 38898951